Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

30 trials with published results (20%)

Research Maturity

97 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.1%

6 terminated out of 147 trials

Success Rate

94.2%

+7.6% vs benchmark

Late-Stage Pipeline

31%

46 trials in Phase 3/4

Results Transparency

31%

30 of 97 completed with results

Key Signals

30 with results94% success

Data Visualizations

Phase Distribution

130Total
Not Applicable (42)
Early P 1 (6)
P 1 (16)
P 2 (20)
P 3 (26)
P 4 (20)

Trial Status

Completed97
Unknown17
Not Yet Recruiting9
Recruiting9
Terminated6
Withdrawn4

Trial Success Rate

94.2%

Benchmark: 86.6%

Based on 97 completed trials

Clinical Trials (147)

Showing 20 of 20 trials
NCT06349122Phase 3Not Yet RecruitingPrimary

AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth

NCT05666778Phase 2Active Not RecruitingPrimary

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

NCT07703241Not ApplicableNot Yet RecruitingPrimary

Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25).

NCT07697768Not ApplicableNot Yet Recruiting

Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment

NCT07663838Phase 1Not Yet Recruiting

A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)

NCT05434104Not ApplicableRecruitingPrimary

The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study

NCT07305844Early Phase 1Enrolling By InvitationPrimary

Impact of Clinician-administered Vaginal Live Biotherapeutic Product

NCT07527572Phase 2Not Yet Recruiting

Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

NCT06438575Not ApplicableCompleted

Point of Care Diagnosis of Vaginal Infections

NCT07483671Phase 2Not Yet RecruitingPrimary

Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients

NCT05753813Early Phase 1RecruitingPrimary

Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome

NCT07418918Phase 2CompletedPrimary

Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)

NCT06985433Not ApplicableCompletedPrimary

Light Treatment of Vaginal Infections in Reproductive Age Women

NCT07302035Phase 1Not Yet RecruitingPrimary

A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women

NCT01829204Recruiting

Prospective Data Bank Creation to Study Vaginal Conditions

NCT07247851Not ApplicableCompletedPrimary

Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole

NCT07241871Not ApplicableCompletedPrimary

Performance and Safety of Lactal Gel for Treatment of Bacterial Vaginosis

NCT07234786Not ApplicableRecruitingPrimary

Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections

NCT02946346Not ApplicableTerminated

Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women

NCT06131749Completed

Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa

Scroll to load more

Research Network

Activity Timeline